Ferrara et al. evaluated a “senescent immune phenotype” by measuring the percentage of CD28−CD57+KLRG-1+ cells among circulating CD8+ T lymphocytes from patients with NSCLC treated with ICIs. The gene discussed is KLRG1; the disease is non-small cell lung carcinoma.